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Background:  Individuals with sickle cell trait (SCT) typically do not suffer any health 
complications; however, adverse effects associated with SCT can occur, especially under 
extremely physical conditions.  The National Collegiate Athletic Association (NCAA) mandates 
SCT testing for all incoming freshmen or transfer students-athletes.  The NCAA SCT screening 
program has been controversial; organizations, such as the American Society of Hematology 
(ASH), instead recommend implementing universal interventions (e.g. monitored work-rest 
cycles) to protect all student-athletes, regardless of SCT status, from exercise-related injuries.  
Concerns about the program stems from its mandatory nature and how the program can impact 
student-athletes, with potential harm through stigmatization and discrimination. 
Screening programs can often be effective and important public health interventions; 
however, when any program is mandatory in nature, their appropriateness should be 
investigated.  Despite the direct impact of the program on them, student-athletes’ perceptions of 
the program have not been thoroughly assessed.  The purpose of this study was to elicit 
student-athletes’ thoughts and feelings toward the NCAA program to learn about their 
perceptions and to evaluate the ethical concerns about the program. 
UNIVERSITY OF PITTSBURGH STUDENT-ATHLETE PERCEPTIONS AND 
ETHICAL EVALUATION OF THE NCAA SICKLE CELL TRAIT  
SCREENING PROGRAM 
Rosalie Ferrari, M.S. 
University of Pittsburgh, 2014 
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Methods:  Qualitative interviews were conducted with freshmen or transfer student-
athletes at the University of Pittsburgh.  The interviews were transcribed and coded using 
qualitative thematic analysis and analyzed. 
Results:  Sixteen student-athletes were interviewed.  Participants were supportive of the 
NCAA policy, due to their perception of SCT as a significant health concern.  Furthermore, 
participants were in favor of genetic counseling which provided understanding of screening 
rationale.  Participants did not readily raise concerns the ASH had identified, such as 
stigmatization or discrimination; moreover, student-athletes were hesitant to endorse 
implementation of universal interventions, worrying such measures may hinder athletic 
performance.   
Conclusion:  This study reflects the attitudes of a small number of student-athletes at the 
University of Pittsburgh.  Future studies are needed in order to evaluate the perceptions of 
student-athletes at other institutions.  Despite the lack of student-athletes expressing ethical 
concerns, a non-mandatory “opt-in” screening program that includes genetic counseling, 
combined with the implementation of universal precautions, could achieve the health-promoting 
goals of the NCAA with regard to SCT and would be more ethically sound. 
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1.0  INTRODUCTION 
Sickle cell trait (SCT) is a genetic condition present in approximately 1 in 12 African-Americans 
in the United States.  Individuals with SCT have one copy of the functioning hemoglobin gene 
(Hb A) and one copy of the sickling hemoglobin gene (Hb S), and are said to be sickle cell 
carriers.  Although SCT is typically considered a benign condition, research has shown that 
under intense, physical conditions various adverse health consequences can occur.  Known as 
exertional sickling, the process is characterized by the accumulation of sickled red blood cells in 
the bloodstream, which can cause rapid muscle break down, rhabdomyolysis, and potentially 
sudden death.  Previous cases involving the sudden death of young athletes with SCT have been 
reported.  In the last three decades there have been 23 sudden deaths of athletes associated with 
SCT in middle school, high school, and college (Harris, 2012). 
 In 2010, the National Collegiate Athletic Association (NCAA) legislative council 
approved mandatory testing for SCT for all athletes participating at the Division I level; the 
mandatory screening program was extended to the Division II level in 2012 and to the Division 
III level in 2013 (Bonham, 2010; Thompson, 2011).  The policy has been met with controversy.  
Organizations, such as the American Society of Hematology (ASH) and the Secretary’s 
Advisory Committee on Heritable Disorders in Newborns and Children (SACHDNC) among 
other physician and sickle cell advocate groups, oppose the ruling and recommend that universal 
interventions instead be implemented to protect all athletes from exercise-related injuries and 
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sudden death regardless of their SCT status (Nelson, 2013).  Concerns about the NCAA SCT 
screening program focus in large part on the mandatory nature of the program.  Mandatory 
testing is considered to undermine autonomy, circumvent informed consent, and threaten 
privacy.  The NCAA program is especially problematic because it initially failed to mandate that 
individual education or genetic counseling occur prior to testing (Aloe, 2011).  In order to 
address this latter concern, the University of Pittsburgh, with the help of the 
Hematology/Oncology department of Children’s Hospital of Pittsburgh, developed, and in 2009 
implemented, a process for mandatory SCT screening which includes genetic counseling for the 
incoming freshmen and transfer student-athletes who must be tested under the NCAA policy.        
 This project aimed to learn University of Pittsburgh student-athletes’ perceptions of the 
NCAA SCT screening program and to evaluate both their perceptions and the program in light of 
ethical concerns raised in the literature with regard to the NCAA’s mandatory screening policy.  
Sixteen semi-structured interviews were conducted to elicit student-athletes’ thoughts and 
feelings about the SCT policy, the testing process, and the relevance of learning their SCT status.  
The interviews were voluntary, and verbal informed consent was obtained; all interviews were 
audio recorded, transcribed, and analyzed using qualitative thematic analysis.  The ultimate goal 
is of this project is to evaluate the ethical merit of the NCAA mandatory SCT screening program 
and to help ensure that the benefits of genetic counseling are afforded to student-athletes 
subjected to this screening program.    
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1.1 BACKGROUND AND SIGNIFICANCE 
1.1.1 Sickle Cell Disease 
Sickle cell disease is a genetic condition characterized by the presence of Hemoglobin S (Hb S) 
which produces red blood cells with a sickle-shape.  The condition typically manifests during 
infancy or early childhood, and major phenotypic features include anemia, infarction, and 
asplenia (Nussbaum, 2007).  Hemoglobin is composed of four heme chains, two α chains and 
two β chains, and functions by carrying oxygen throughout the body.  The α-hemoglobin chains 
are encoded by HBA on chromosome 16 and the β-hemoglobin chains are encoded by HBB on 
chromosome 11.  Sickle cell disease is associated with mutations in HBB and comprises a variety 
of symptomatic disorders, the most common being sickle cell anemia in which both copies of the 
HBB gene are mutated (Bender & Hobbs, 2012).  The hallmark sickle cell shape of Hb S is 
caused by a single point mutation in HBB at amino acid six from glutamic acid to valine.  The β-
hemoglobin mutation Hb S has decreased solubility when deoxygenated compared to the 
standard adult hemoglobin, Hb A, and results in the production of stiff fibrous polymers which 
distort the red blood cell from its normally smooth, circular shape (Costanzo, 2011; Nussbaum 
2007).  The sickled cells can become affixed to each other and cause blockages in capillaries, 
illustrated in Figure 1. 
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          (National Heart, Lung, and Blood Institute, NIH, 2012)
Figure 1  Comparison of normal red blood cells and sickled red blood cells 
Sickle cell disease presents in a variable, multisystem fashion; the sickled cells can cause 
vasoocclusive infarctions in many tissues contributing to pain crises, acute chest syndrome, 
cerebrovascular complications, as well as splenic and renal dysfunction (Ashley-Koch, 2000; 
Chelcun, 2014; Nussbaum, 2007).  The most common reason for hospitalization for individuals 
with sickle cell disease is vasoocclusive pain crises (Thompson, 2011).  Individuals with sickle 
cell disease also have an increased susceptibility to bacterial infections including pneumonia, 
meningitis, osteomyelitis, and sepsis due to functional asplenia; throughout their lives these 
infections increase the risk of death, while pulmonary and renal failure typically are attributed 
with deaths occurring in the fourth and fifth decades (Chelcun, 2014; Nussbaum, 2007).   
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Sickle cell disease results in chronic hemolytic anemia with varying severities of anemia, 
jaundice, cholelithiasis, and vasculopathy (Chelcun, 2014).  The average red blood cell has a 
lifespan of approximately 120 days; a sickle red blood cell has a lifespan of approximately 20 
days, which accounts for the anemia manifestation of the disease (Lawrence, 2010).  Individuals 
with the highest rates of hemolysis are more likely to develop vasculopathy compared to 
individuals with lower rates of hemolysis, who are more prone to episodes of acute pain (Bender 
& Hobbs, 2012; Rees, 2010). 
 Sickle cell disease is the most common inherited blood disorder in the United States and 
affects millions of individuals worldwide.  The disease affects an estimated 70,000 to 80,000 
Americans, and the incidence is one in every 500 African Americans (Aloe, 2011; Thompson, 
2011).  Although the heterozygous state is present in approximately 8% of the African-American 
population, the disease can be seen in a number of different ethnicities including individuals of 
Mediterranean, Caribbean, Middle Eastern, and Indian descent (Ashley-Koch, 2000; Costanzo, 
2011; Nussbaum, 2007).  Sickle cell disease is an autosomal recessive disorder; thus the disease 
manifests when two abnormal hemoglobin genes are inherited.  Although, the homozygous Hb S 
mutations account for the majority and most severe presentation of sickle cell disease cases, 
compound heterozygote cases of the disease can occur with Hb S and other β-hemoglobin chain 
mutations, commonly with hemoglobin C (Hb C), hemoglobin D (Hb D), and β-thalassemia 
(Ashley-Koch, 2000; Bender & Hobbs, 2012; Aloe, 2010).  If both parents are carriers of a sickle 
cell disease mutation, each of their pregnancies would have a 25% chance of a child with sickle 
cell disease, a 50% chance of being unaffected and a carrier, and a 25% chance of being 
unaffected and not a carrier.   
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In the United States, universal screening programs for sickle cell disease are conducted at 
birth, which can facilitate early access to prophylaxis with penicillin, comprehensive care, and 
education about the detection of disease-related complications (Key, 2010; Rees, 2010).  
Management of sickle cell disease involves routine medical management (e.g., CBC count, 
pulmonary function tests, echocardiogram), prevention and treatment of pain crises, and 
management of specific problems.  Continued monitoring of individuals with sickle cell disease 
is recommended to ensure preventive interventions, such as maintaining hydration and avoiding 
extreme conditions, are being utilized (Bender & Hobbs, 2012).  Other therapies used or 
currently being investigated for the treatment of sickle cell disease include blood transfusions, 
stem cell transplantation, and administration of hydroxyurea which helps by increasing the 
synthesis of fetal hemoglobin and reducing the number of sickled cells, thus decreasing the 
frequency of pain crises (Charache, 1995; Rees, 2010).  
1.1.2 Sickle Cell Trait 
Sickle cell trait affects approximately 3 million Americans and is characterized by the presence 
of both Hb S and Hb A (Bender & Hobbs, 2012; Costanzo, 2011; Lawrence, 2010).  Also known 
as  sickle cell carriers, individuals with SCT have a heterozygous genotype of Hb AS and have 
variable hemoglobin compositions of less than 50% Hb S, generally ranging between 20-45% 
(Aloe, 2010; Key; 2010; Tsaras, 2009).  Not considered a form of sickle cell disease, SCT is 
considered an asymptomatic condition.  SCT has no impact on life expectancy and actually may 
afford an evolutionary benefit since carriers have lower rates of mortality from malaria infection 
compared to noncarriers, Hb AA (Ashley-Koch, 2000; Goldsmith 2011).  Worldwide, an 
estimated 300 million have SCT.  The prevalence of SCT in newborns in the United States is 
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~1.3% (Goldsmith, 2011; Grant, 2011; Key, 2010).  However, reports of specific adverse health 
effects associated with SCT have been described and are outlined in Table 1.   
Table 1 Complications of SCT 
Definite Associations Probable Associations Possible Associations 
 
• Decreased malaria deaths 
• Exercise-related deaths 
• Exertional rhabdomyolysis 
• Hematuria and renal papillary 
necrosis 
• Hyposthenuria 
• Renal medullary carcinoma 


















(Adapted from Goldsmith, 2011; Key, 2010; Tsaras, 2009) 
 The amount of sickling that occurs in individuals with SCT varies and is dependent on a 
number of factors, such as amount of Hb S present, the degree of hypoxia, and other factors 
contributory to exertional sickling events (Costanzo, 2011; Nussbaum, 2007).  During intense 
exercise, SCT appears to be a risk factor for sudden death and/or rhabdomyolysis potentially due 
to exertional sickling.  Conditions that appear to increase these risks include extreme physical 
activity or exertion at high altitude, especially when an individual is dehydrated or hyperthermic 
(Key, 2010; Lawrence, 2010).  The most conclusive data of the association between SCT and 
sudden death comes from studies of the members of the US military.  In 1987, an approximately 
28-fold increased risk of exercise-related sudden death in US Army recruits with SCT, compared 
to those recruits without SCT, was reported in a cohort study of 2 million enlisted recruits (Kark, 
1987). 
 Although exercise-related sudden deaths are generally rare, there is growing concern over 
the number of deaths among athletes with SCT.  Within the last decade, out of 136 non-traumatic 
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sports deaths in high school and collegiate athletes, seven (5%) were considered to be due to 
exertional sickling (Thompson, 2011).  Experts do not agree about the underlying 
pathophysiological means leading to sudden death in those with SCT, reports of sudden death for 
student-athletes with SCT have prompted the NCAA to enact mandated SCT screening for all 
student-athletes.  This mandated screening program has been criticized, with those opposed to 
mandatory screening instead recommending effective prevention of exertional sickling events 
through universal interventions– i.e. interventions applied to all athletes regardless of their SCT 
status–  including gradual buildup of performance levels, adequate hydration during exercise, 
ingestion of salt and potassium as required due to excessive sweating, and cessation of activity 
with onset of muscle cramping, fatigue, and shortness of breath (SACHDNC, 2010).  Advocates 
of universal interventions disagree with the implementation of the SCT screening policy without 
clear supporting medical evidence that SCT is the underlying cause of sudden death.  The 
primary concern is that student-athletes with SCT could be distinguished from other student-
athletes based on the precautions required for SCT positive student-athletes after the NCAA 
determines their status (e.g., setting their own pace during practices) may lead to those 
individuals with SCT to suffer possible social and ethical harms, including loss of privacy, 
stigmatization, and discrimination (Thompson, 2013). 
1.1.3 Sickle Cell Trait Testing Methodology 
The laboratory detection for hemoglobinopathies, including SCT, has relied on three main 
observations (Benson, 2010):  
1. The appearance of sickled red blood cells 
2. Solubility of Hb S 
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3. Diagnostic hemoglobin profiles  
Testing for SCT involves a blood draw.  One method requires a sample of blood to be placed on 
a microscope slide and sealed with a cover slip, depleting the sample of oxygen and 
consequently causing Hb S to sickle and thus be visible using a microscope (Thompson, 2011).  
A second method is a solubility test (e.g. Sickledex) the test utilizes buffers, lysing agents, and 
reducing agents in combination with the sample of blood.  Samples containing Hb S become 
cloudy in the solution, due to its insoluble nature in high molarity solutions (Costanzo, 2011; 
Hara, 1973).  The limitation of both methods, however, is their inability to identify other sickle 
cell disease disorders, such as Hb C, since the methods are used solely to detect the presence of 
sickled cells (Aloe, 2010).  Results can also be misleading since an individual with a high 
hemoglobin level may present with a false positive result, while an individual with a low 
hemoglobin level may have a false negative result.  Nevertheless, the advent of these 
technologies allowed for an increase capability of high analytical throughput, and population-
wide screening became feasible (Benson, 2010).   
In order to confirm SCT status, as well as to differentiate the hemoglobin genotypes, 
samples can be run using electrophoresis or high-performance liquid chromatography (HPLC).  
Both methods can be effective to diagnose SCT.  Hemoglobin variants, like Hb S, have particular 
charges based on the respective amino acid substitution (e.g. Hb A, has the negatively charged 
glutamic acid substitution compared to Hb S, which has the neutral valine amino acid) 
(Lawrence, 2010).  The charge of the hemoglobin variant will dictate the movement during 
testing; however, if the hemoglobin variants have the same or similar charges (e.g. Hb S and Hb 
C), DNA analysis with gene sequencing may be necessary (Thompson, 2011).  Therefore, there 
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is a possibility that individuals have incidental findings revealed (e.g. Hb C status) when 
verifying SCT status.    
1.1.4 History of Sickle Cell Testing 
Sickle cell disease was first described in the early 20th century when James B. Herrick 
discovered sickled cells in the blood of one of his interns, an anemic graduate student (Aloe, 
2010; Rees, 2010).  In 1949, Linus Pauling and his colleagues were the first to use 
electrophoresis to distinguish normal and abnormal hemoglobin and to demonstrate that sickle 
cell disease was a molecular disease (Benson, 2010; Costanzo, 2011; Rees, 2010).  Advances in 
technology led to progressive understanding of sickle cell disease throughout the 1950s and 
1960s.  The public health significance of sickle cell disease was acknowledged in 1972 when the 
National Sickle Cell Anemia Control Act (Public Law 92-294) was passed by the U.S. Congress 
and became the first federal program aimed at screening for a specific genetic disease and carrier 
status (Ashley-Koch, 2000; Benson, 2010; Rutkow, 1974).  The act pledged federal funding to 
expand sickle cell screening programs for individual states; in 1974, 10 states had implemented 
mandatory testing of African-Americans for sickle cell (Rutkow, 1974, Thompson, 2011).  The 
Act met with criticism centered on its lack of sensitivity to issues of race, concerns about the 
accuracy and validity of the screening method, and furthermore, inadequate protection of 
individuals’ rights.  Some researchers denounced the programs and claimed that individuals 
found to have any abnormality were being discriminated against in addition to not receiving 
adequate counseling or education regarding the result (Lawrence, 2011; Rutkow, 1974).    
 Even though expansions of screening programs for sickle cell disease were controversial, 
governmental grant support allowed screening programs to be implemented.  In 1975, the first 
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newborn screening (NBS) program for sickle cell disease began in New York, and by 2006 all 50 
states had instituted universal mandatory testing for all newborns (Ashley-Koch, 2000; 
Thompson, 2011).  The mortality and morbidity associated with sickle cell disease has decreased 
since NBS programs have been utilized.  Early diagnosis, effective medical care, and education 
provided to family members has allowed individuals with sickle cell disease to live into 
adulthood and have an improved quality of life by managing sickle-cell related symptoms. 
 In addition to mandatory screening programs for sickle cell disease, screening programs 
for SCT were established in the U.S. military.  In 1970 screening for SCT was recommended for 
incoming African-American military recruits due to concern over presumed complications 
associated with SCT, including the occurrence of sudden death (Binder, 1970).  Once the Control 
Act passed in 1972, certain branches of the military, such as the U.S. Air Force, began screening 
all recruits for SCT and restricted individuals with SCT from flight duties (Brodine, 1977; 
Costanzo, 2011).  However, by 1985 the U.S. Department of Defense removed all recommended 
restrictive measures for all sickle cell carriers in the military (Thompson, 2011).  The U.S. Air 
Force adjusted its SCT screening practices slightly; all recruits are screened for SCT but those 
who test positive are offered the option to decline service (Grant, 2013; Mitchell, 2007).  Other 
branches of the military have similar policies.  Both the U.S. Marines and the U.S. Navy screen 
recruits for SCT.  The Marines do not alter routine duties for those identified with SCT, while 
the Navy identifies those with SCT through a neck tag and a red belt during intense drills 
(Mitchell, 2007).  Only the U.S. Army terminated its SCT screening program for recruits as of 
1996 (Aloe, 2010; Grant, 2013; Thompson, 2011).   
The NCAA mandated SCT screening program at the Division I level began in 2010.  The 
screening program is expected to identify 2,000 Division I student-athletes with SCT and prevent 
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approximately 7 deaths of individuals with SCT over a decade (Tarini, 2012).  The major 
apparent cause of sudden death associated with SCT and exercise is exertional heat illness (EHI) 
(Kark, 1994).  A number of precautions have been recommended in an effort to avoid these 
potentially grave consequences.  The U.S. Army mitigates the risk of EHI by employing 
universal preventive measures which include heat acclimatization, monitored work out and rest 
cycles, guidelines for nutrition and hydration, and staff preparedness for the early detection of 
possible symptoms (ASH Statement on Screening for Sickle Cell Trait and Athletic 
Participation, 2012).  The NCAA also developed preventive measures for athletes with SCT; 
although the committee selected to do so, established rules only for football and not all sports 
programs.  Both the U.S. Army and NCAA programs strive to reduce the effect of exercise-
related sudden death, the main distinguishing feature between the two programs lies in the role of 
SCT testing: the NCAA mandates SCT testing while the U.S. Army program eliminated its SCT 
screening program while still seeking to protect recruits. 
The controversy surrounding SCT screening programs has been evident since the 1970s.  
Programs have been scrutinized due to lack of sensitivity to race, poor design or implementation, 
and concerns about lack of informed consent, risks of discrimination, breaches of privacy, and 
potential stigmatization.  From the inception, screening programs were focused on targeted 
screening of the African American population since SCT has a higher frequency among 
individuals of African descent, even though SCT is also commonly seen in individuals of 
Mediterranean, Caribbean, Middle Eastern, and Indian descent (Ashley-Koch, 2000; 
SACHDNC, 2010).  Moreover, there is a tension in SCT screening programs between giving 
priority to prevention of adverse health consequences and providing adequate information about 
testing (Atkin, 1998).  Although the NCAA is motivated to protect the health of student-athletes, 
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including those with SCT, the rationale behind its program may not be evident to the student-
athletes targeted for the mandated SCT testing (Costanzo, 2011).  
 The U.S. military’s initial SCT screening programs illustrate how the targeted nature of 
the policy resulted in discrimination and stigmatization, with the restriction of duties of those 
testing positive (e.g. barring them from flight duty or diving), which were typically the most 
prestigious, desirable, and remunerative duties, as well as being the less menial jobs in the 
military.  African-American men who tested positive were frequently relegated to more menial 
or supportive roles, mirroring the type of employment discrimination and “ghettoizing” 
experienced in the broader American society of the time.  In addition to concentrating on 
identifying individuals with a single condition rather than developing effective universal 
interventions for all individuals (Grant, 2013), the military’s approach reflects an approach taken 
in numerous employment contexts where the attitude is to eliminate “risky or at-risk workers” 
rather than reducing the risk to them and their fellow employees (Draper, 1991).  Finally, it is 
now recognized that current SCT screening programs should address issues relating to the 
privacy of individuals’ health information (Thompson, 2011), which military programs that 
marked SCT positive recruits with tags and red belts fail to do.  Individuals have a right to 
maintain the privacy of their health information, including their genetic information.  This ethical 
right is the foundation for legal rights to privacy protection, for example, afforded by the Health 
Insurance Portability and Accountability Act (HIPAA).  HIPAA protects the privacy of 
individuals, in regard to their identifiable health information, by setting national standards 
securing electronic health information, as well as regulating the sharing of non-electronic 
information (U.S. Department of Health & Human Services, 2013).  Individuals’ genetic 
information is included under HIPAA and remains private unless an individual authorizes a 
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release (Francis, 2010).  It must be noted, however, that HIPAA only applies to specific covered 
entities that typically have access to individuals’ health information in the course of their 
operation (e.g. clinics, hospitals, or insurance companies).   
1.1.5 Public Health and Ethical Considerations for Establishing a Screening Program  
Public health interventions are designed and implemented to promote and protect the health of 
those composing the community; however, such interventions have the potential to infringe on 
individual’s rights or interests for the sake of promoting the public or collective good.  Criteria 
have been established in the public health ethics community to minimize the effect on 
individuals’ rights and welfare of public health measures (Gostin, 2000).  Like any mandatory 
public health policy, to be ethically justified, a mandatory SCT screening program should meet 
these criteria.  As described by Gostin, public health interventions are more acceptable when 
criteria used to justify these programs demonstrate that: 
1. The intervention addresses a significant risk   
2. The intervention is effective  
3. It may be implemented at reasonable cost 
4. It justly distributes benefits, burdens, and costs 
A stepwise approach in evaluating a public health intervention is discussed below and can be 
found in Figure 2.  
A fundamental objective of public health is to reduce harm to the public’s health by 
identifying potential risks.  Therefore, conducting a thorough risk analysis is an imperative step 
to justify development and implementation of a public health intervention.  Risk analysis should 
be done objectively with emphasis placed on scientific support.  The process should involve a 
 14 
multidisciplinary effort in order to assure reasonable actions are undertaken without the 
emergence of conflicts such as motivation of actions due to irrational fears (Gostin, 2000).  By 
evaluating four factors concerning any given risk, a more comprehensive risk assessment can be 
completed.  These factors include determining the nature of the risk (various sources can present 
distinct risks), the duration of the risk (risks can be static or dynamic), the probability of harm 
(the chance the harm will occur), and the severity of harm (the effect and extent of the harm) 
(Gostin, 2000). 
Public health interventions should also consider whether the means of their 
implementation actually are effective and produce the desired outcome (i.e. reduce the risk or 
amend the harm).  It is important to note, the process of demonstrating an intervention’s 
effectiveness should be a recurrent act and not merely a one-time occurrence (Gostin, 2000).  
Inherently tied to a public health intervention’s effectiveness is the associated economic cost.  
Given limited resources, “cost-effective” interventions, i.e. those that provide considerable health 
benefit with the least cost are desirable.  In addition to weighing the cost of an intervention, the 
effect an intervention has on individuals’ rights (e.g. autonomy and privacy) should also be 
evaluated.  Gostin describes certain questions that should be addressed in order to assess the 
personal burden an intervention may produce; these include “1- invasiveness: to what degree 
does the public health intervention intrude on the right in question? 2- frequency and scope: does 
the infringement of rights apply to one person, a group, or an entire population? 3- duration: how 
long a period is the person or group subject to the infringement?” (Gostin, 2000).  When 
developing and implementing an intervention, it is preferable to develop one which is “least 
intrusive” while still having the potential to achieve the objective.  This means that the 
intervention seeking social benefit or collective good should intrude as minimally as possible on 
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the other important values and rights.  Therefore, to justify mandatory screening in the public 
health context, the above criteria and considerations should be addressed, because in virtue of 
being mandated, such programs have the potential to violate an individual’s autonomy (Hodge, 
2004). 
Finally, the fairness of a public health intervention should be assessed.  Assessment of 
fairness requires a combined analysis of the benefits, burdens, and costs to ensure their proper or 
fair allocation.  Since interventions often target a population, it is important to consider who will 
bear the intervention’s burdens and who will benefit; ideally, it is those who stand to benefit who 
bear the burdens of the intervention.  Moreover, care must be taken to avoid either 
underinclusiveness or overinclusiveness (Gostin, 2000).  In the public health context, 
overinclusiveness can be ineffective since people receive services they do not need or bear 
burdens unnecessarily, while being under-inclusive would fail to provide service to those who 
need them, or would fail to spread sufficiently the burdens of an intervention.  
                                        A dapted from Gostin, 2000
Figure 2 Stepwise measures involved in establishing a public health intervention 
It is important to note that the inclusion of informed consent, and the implied possibility 
to refuse as an integral part of voluntary consent, is not consistent with the mandatory nature of 
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screening programs.  Often times, certain provisions are made for individuals who refuse to 
participate in mandatory programs, for example for deeply held religious beliefs.  Such refusal is 
documented by signing a waiver indicating that they opt out.  An ideal screening program should 
provide sufficient information to an individual, through education and counseling, so that the 
individual can decide whether to participate.  In the case of mandatory genetic screening 
programs, though providing adequate education and effective genetic counseling cannot address 
the lack of informed consent entailed by the program’s mandatory nature, can make those tested 
more aware of the risks involved so that they can take steps to mitigate them.   
One of the most recognized mandatory screening programs is NBS.  Today, nearly every 
individual born undergoes NBS, which began in the 1960s.  NBS strives to identify individuals 
with genetic conditions in order to provide early interventions or treatment which can decrease 
the associated morbidity and mortality (Tarini, 2012).  Each state’s public health department is 
responsible for and has authority over its respective NBS programs; therefore conditions 
included on screening panels vary from state to state (Harwood, 2013).  Initial criteria used to 
justify NBS and many of its’ subsequent expansions were developed by Wilson and Jungner in 
1968 (Arnold, 2013).  These criteria include that:     
1. The condition is an important health problem 
2. An accepted treatment exists 
3. Facilities for diagnosis and treatment are available 
4. There is a recognizable latent or early symptomatic period 
5. A suitable test or examination exists 
6. The test is acceptable to the population 
7. The natural history of the condition is adequately understood 
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8. There is policy agreement on whom to treat as patients 
9. The cost of case-finding (including diagnosis and treatment) is balanced with regard to 
the possible expense of medical care.    
Although NBS has, in general, benefitted from public acceptance, certain ethical issues have 
been raised concerning the programs, including matters pertaining to adequate parental 
consent/education, retaining and use of blood samples after screening, and communications of 
results (Tarini, 2012).  Furthermore, public health policies are often driven by scientific 
advancement and related potential to protect health.  Therefore, as technology has evolved 
additional conditions are being advocated for inclusion on NBS panels even when they do not 
meet the Wilson and Jungner criteria (Kraszewski, 2006), prompting criticism that NBS 
programs are susceptible to the “technological imperative” (Hofmann, 2002).  
 Points of analogy and dis-analogy can be drawn between NBS programs and SCT 
screening programs.  Both seek to gather information about an individual in order to directly 
benefit that individual and both present ethical challenges.  In 2009, the CDC hosted a meeting 
on SCT, discussed the public health implications and issued recommendations in order to 









Table 2 Recommendations for SCT screening programs 
 
Programs should attempt to 
minimize discrimination, 
exclusion, and stigma based 
on SCT status 
 
Policies should protect an 
individual’s privacy and 
reduce redundant screening 
procedures 
 
Research that monitors 
ethical, legal, and 
psychosocial results of 
screening programs 
 
(Adapted from Grant, 2011) 
1.1.6 NCAA Sickle Cell Trait Student-Athlete Screening Program 
The NCAA approved mandatory testing for all student-athletes for SCT at the Division I level on 
April 13th, 2010 (Bonham, 2010).  The screening program has since been extended to include 
mandatory testing at the Division II and Division III levels.  The impetus for the implementation 
of a genetic-based population-wide screening program for SCT was the 2006 death of Dale 
Lloyd II, a Rice University football player.  The freshman student-athlete’s death was caused by 
acute exertional rhabdomyolysis and was associated with his unknown SCT (Aloe, 2010; 
SACHDNC, 2010).  Lloyd’s family filed a lawsuit against both the NCAA and Rice University 
in order to raise awareness of the potential adverse health consequences associated with SCT for 
student-athletes (Costanzo, 2011).  Over the last decade, a number of sudden deaths occurred in 
student-athletes at the college level who were unaware of their SCT status (Bonham, 2010).  
Although SCT screening is typically performed as part of NBS for sickle cell disease, the results 
are often not disclosed to parents or the newborns’ clinicians.  Thus, the NCAA now requires 
SCT testing, through a sickle cell solubility test, as part of the medical examination for all 
freshmen and transfer student-athletes unless the student-athlete chooses to decline testing by 
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providing documented results of a prior test or signing a written waiver release (NCAA Sports 
Medicine Handbook, 2013-2014).  The adoption of a waiver was not designed to discourage 
student-athletes from participating in the screening program but rather to give student-athletes an 
opportunity to decline participation (Thompson, 2011).  The document shields the given 
institution and the NCAA from liability for harms that could result due to athletic participation 
without determining SCT status (Appendix B.2).  The NCAA also requires that student-athletes 
who sign a waiver be provided “additional education regarding the risks, impact, and precautions 
associated with sickle cell trait” beyond the general educational material provided to all student-
athletes concerning SCT (NCAA Sports Medicine Handbook, 2013-2014).   
The NCAA developed precautions for student-athletes with SCT as well as their trainers 
and institutions in order to prevent the adverse health outcomes associated with SCT (Table 3).      
Table 3 NCAA recommended precautions for student-athletes with SCT 
Manage their individual pace 
Engage in a measured preseason conditioning to be prepared for sports-specific performance 
testing and the rigors of competitive collegiate athletics 
Build up gradually while training (e.g. paced progressions) 
Use adequate rest and recovery between repetitions 
Not be persuaded to perform all-out exertion of any kind beyond two to three minutes without 
a rest 
Be excused from certain performance tests (e.g. serial sprints) 
Stop activity immediately upon difficulty or experiencing symptoms such as muscle pain 
Stay well hydrated at all times 
Maintain proper asthma management 
Refrain from extreme exercise during illnesses (e.g. experiencing a fever) 
Access to supplemental oxygen at altitude if needed 
Seek medical care when experiencing unusual distress 
 
(Adapted from NCAA Sports Medicine Handbook, 2013-2014) 
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 Although, the NCAA cites “growing support for the practical benefits of screening,” the 
NCAA SCT screening program has been criticized due in large part to the contentious evidence 
regarding the connection between sudden death occurrences and exertional sickling, and the 
mandatory nature of the program given the potential social, behavioral, and psychological 
implications for those with SCT (Bonham, 2010; Lawrence, 2010; NCAA Sports Medicine 
Handbook, 2013-2014; SACHDNC, 2010).  Like other mandatory screening programs, the 
NCAA SCT screening program raises a number of ethical considerations surrounding the 
balancing of individuals’ rights, including the right of informed consent for healthcare 
interventions, and the health-related value of identifying those at risk.  The NCAA program also 
must contend with the reality that more African American student-athletes will be identified with 
SCT than other racial groups.  Due to the past history of racial issues associated with 
governmental and military SCT screening programs, there is a possibility the NCAA screening 
program will provoke similar problems with an exacerbation of stigma when racial identities 
intersect.  Furthermore, the NCAA has yet to develop any policy seeking to protect student-
athletes with SCT against discrimination (SACHDNC, 2010).  For these reasons, the American 
Society of Hematology and the Sickle Cell Disease Association of America do not support the 
NCAA’s mandated SCT screening program and instead recommend implementing universal 
interventions for all athletes (SACHDNC, 2010).  This approach would require the NCAA to 
consider whether altering the underlying culture of college athletics by instituting universal 
interventions would be more beneficial than population-wide testing followed by targeted 
interventions (Bonham, 2010).      
The NCAA policy’s emphasis on education is heralded by both those opposed to and 
those supportive of the NCAA program.  All endorse SCT awareness and ensuring that athletes, 
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coaches and trainers understand the condition and recognize the symptoms associated with heat 
related illness.  Such understanding may facilitate prompt and appropriate health care for an 
individual if needed (NCAA Sports Medicine Handbook, 2013-2014; SACHDNC, 2010).  
However, the NCAA mandate itself initially lacked any recommendation that student-athletes 
receive education regarding SCT during the screening process (Thompson, 2011).  Since 
extending the SCT screening program to other division levels, the NCAA has required that each 
student-athlete be provided with education regarding SCT through NCAA bylaw 17.1.6.4.1.1 
(NCAA Sports Medicine Handbook, 2013-2014).  However, the bylaw does not state what 
constitutes “education”; therefore each institution can have differing standards of SCT education.   
1.1.7 Broader Implications of the NCAA Mandatory SCT Program 
Among the broader implications of the NCAA program is concern that the emergence of one 
mandatory genetic screening program may generate additional, potentially mandatory, genetic 
screening programs by making them more socially acceptable and perhaps establishing their cost 
effectiveness and efficacy with regard to a desired health outcome.  The most common non-
traumatic cause of NCAA student-athletes deaths is inherited cardiac arrhythmia and 
cardiomyopathy syndrome (Bonham, 2010; Harmon, 2011).  The high public profile of these 
sudden cardiac death cases has increased support for cardiovascular screening directed at 
student-athletes even at the high school level (Glover, 2007).   
The NCAA mandates a pre-participation cardiovascular evaluation for all Division I, II, 
and III level student-athletes prior to their first athletic involvement (e.g. practice) which 
includes assessment of family history and physical examination (Aloe, 2010).  Currently, the 
requirement is less invasive since it does not require an individual submit a sample of blood for 
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genetic testing as the SCT screening program does; however that may not always remain the 
case.  Cardiovascular genetics is an evolving and complex discipline; as more genes are being 
identified that are associated with cardiovascular disorder most notably with susceptibility to 
hypertrophic cardiomyopathy (Thompson, 2011).  Given the potential apparent attractiveness of 
perhaps instituting screening for these cardiovascular-related genetic mutations, it is important to 
scrutinize the justification proffered for the mandatory NCAA SCT screening program due to its 
potential precedent-setting role.  
1.1.8 University of Pittsburgh SCT Screening Program 
The University of Pittsburgh, with the help of the Hematology/Oncology department of 
Children’s Hospital of Pittsburgh, developed a SCT screening program for student-athletes that 
includes genetic counseling.  SCT counseling and testing is organized through the athletic 
training coordinator and often held concomitantly with student-athlete physicals.  If needed, 
additional testing dates are arranged during which student-athletes receive genetic counseling.  
The University of Pittsburgh has participated in the NCAA SCT screening program since 2009, 
and before it became mandatory, offered testing on a voluntary basis (Costanzo, 2011).  Testing 
is billed through each student-athlete’s personal insurance plan or in the absence of such 
insurance through the insurance provided by the athletics department.  In 2009, initial education 
of athletic personal regarding SCT genetic testing was presented through a PowerPoint lecture by 
former University of Pittsburgh genetic counseling student, Amy Aloe.  It included information 
concerning sickle cell disease, SCT, and the NCAA’s recommendations regarding SCT.  Annual 
genetic counseling of student-athletes includes succinct summaries of the screening rationale, 
types of possible test results, implications of results, symptoms of and precautions for SCT, and 
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information about the testing procedure, as well as information about the reproductive 
significance of SCT.  Student-athletes are each provided with literature explaining the health 
related significance of SCT (See Appendix B.3).  Each student-athlete participates in an 
informed consent process and signs a consent form prior to undergoing testing [See Appendix 
B.1].  If a student-athlete declines testing, a waiver must be signed releasing the university from 
liability for harm associated with the student-athlete not confirming his/her SCT status [See 
Appendix B.2].  The University of Pittsburgh athletic department is provided with each student-
athlete’s result for its records.  If a student-athlete is found to be SCT positive, the student-athlete 
is informed.  A more formal, private-individual genetic counseling session is arranged to discuss 
the implications for the student-athlete.  In addition, review of SCT education is provided for the 
athletic trainers involved in the student-athlete’s training and care. 
 The University of Pittsburgh has a distinctive SCT program insofar as genetic counseling 
is provided.  Past research has shown that college student-athletes at other institutions as well as 
at the University of Pittsburgh may not have an adequate understanding of the mandated NCAA 
SCT screening program or SCT (Costanzo, 2011; Lawrence, 2010).  The purpose of the research 
project reported here is to understand in greater detail student-athletes’ thoughts, feelings, 
opinions, and concerns with regard to the SCT screening program.  Student-athletes’ responses 
suggest ways to improve not only the University of Pittsburgh SCT screening program but also 
the NCAA SCT screening program.  This research is significant because, first, it informs both an 
ethical analysis of the NCAA SCT program.  Second, it provides the basis for recommendations 
to improve for the University of Pittsburgh SCT program to make the process more responsive to 
the opinions and concerns of the population undergoing genetic testing, as well as ethical 
concerns reported in the literature.  Because the NCAA mandatory SCT screening program is a 
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rare exception to the usual practice of voluntary genetic testing, this ethical analysis of the 
program and of the student-athletes’ concerns is especially important.   
1.2 SPECIFIC AIMS 
This study has three aims for which both qualitative empirical and ethical analysis was 
undertaken.  The first aim of this study was to elicit student-athletes’ thoughts and feelings 
toward the SCT screening program.  The second aim of this study was to conduct a qualitative 
thematic analysis to assess student-athletes’ attitudes toward the SCT screening program and to 
identify concerns they may have.  The third aim of this study was to evaluate the ethical concerns 
expressed in the literature regarding the NCAA SCT screening program, both by comparing 
student-athlete responses to the ethical issues which have been reported and further by analyzing 
the possible ethical implications of such a screening program.   
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2.0  METHODS 
The study was reviewed and approved by the University of Pittsburgh Institutional Review 
Board on September 19th 2013 identified as IRB #PRO13070107 (See Appendix A.1).  The 
study was categorized as an exempt study.  Notification was given to the University of Pittsburgh 
Department of Athletics concerning the study.  Since 2009, the Athletic Department has worked 
jointly with the Department of Hematology/Oncology at Children’s Hospital of Pittsburgh in 
order to provide SCT testing services, including genetic counseling.  The Graduate Assistant 
Athletic Training coordinator, who arranges student-athlete screening days, was informed of the 
study and assisted in organizing interviews.   
A descriptive, guided interview approach was utilized.  This approach ensures the same 
general areas of information are collected; the uniformity maintains a level of focus and 
consistency with the data while still providing freedom and adaptability during each interview 
(Turner, 2010).  All interviews were audio recorded, transcribed, and coded with relevant themes 
and concepts during analysis.  The data analysis method selected was thematic analysis.  The use 
of thematic analysis allows for the identification, analysis and reporting of themes within the 
data. 
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2.1 INTERVIEW PROCESS 
All interviews were scheduled between September and November 2013. 
2.1.1 Participant Recruitment 
Student-athletes were emailed a request to participate in a study interview (See Appendix A.2).  
Graduate assistant athletic trainers helped coordinate scheduling interviews with interested 
student-athletes.  A total of 15 interviews with student-athletes, either freshmen or transfer 
students, during the 2013 fall semester, were sought with the goal of including student-athletes 
involved in a number of different sports in order to obtain various responses of student-athletes 
from different sports teams.  The rationale behind the number of interviews sought was to allow 
for sufficient data from at least ten individuals in order to reach data saturation.  Furthermore, 
responses at that point were believed to represent a general opinion in which the same themes are 
repeated.   
2.1.2 Interview Process 
The study’s aims and methods were explained to all participants and their verbal (oral) consent 
was obtained prior to beginning the interview (See Appendix A.3).  Student-athlete participation 
was voluntary.  Interviews were not expected to exceed 30 minutes.  An interview guide was 
developed and included questions directed at eliciting student-athletes’ thoughts about the SCT 
screening process and results (See Appendix A.4).  All interviews were audio recorded.  At the 
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end of each interview, student-athletes were offered a small token of appreciation (e.g. a sports-
themed beverage and pack of gum) for their participation.            
2.2 DATA ANALYSIS 
Thematic analysis is a commonly used qualitative analytic method.  The goal of thematic 
analysis is to describe a data set in rich detail as themes which are consistent among research 
participants (Turner, 2010).  Thematic analysis was chosen due to its flexible approach to 
analyze data qualitatively (Braun, 2006).  Unlike grounded theory, which has as its goal the 
development of a theory which can serve as an explanation for the topic of interest, thematic 
analysis is used to identify patterns which can serve as a description surrounding a concern.  
Since the purpose of this research was to better understand student-athlete thoughts concerning 
the screening program, thematic analysis was appropriate.  It was also chosen due its 
accessibility as a form of analysis, especially for novice qualitative researchers (Braun, 2006).   
Analysis involved involves a series steps, done in sequential fashion in order to complete 
a thematic analysis of the responsive interviews (Rubin, 2011).  The following is a narrative of 
the main steps performed during the thematic analysis of this research. 
2.2.1 Generating data codes 
After interviews were transcribed verbatim, all transcripts were read to gain a general sense of 
how participants responded to the interview questions.  Each interview was then assessed, in 
sequential order.  It was believed interviews which were earlier in the study process may be more 
 28 
rigid, and as more interviews were conducted there would be a level of comfort obtained.  Thus, 
if responses emerging in beginning interviews were consistent with responses emerging in later 
interviews, then it could be concluded a specific concept, or code, was present.  Coding attempts 
to understand what participants’ meanings were with a particular statement and is a way to mark 
such incidents in the text (Rubin, 2011).  Coding allows for participants’ responses to be 
compared in a relatively easy fashion by summarizing the overall content and connecting the 
data to a concept (Rubin, 2011).  Each interview was read carefully and when a response implied 
a particular code(s), it was noted in the text.  A list of codes for this study can be found in Table 
4, below.       
Table 4  List of themes coded for in interview transcripts 
 
• Attitudes toward University of Pittsburgh screening program 
• Attitudes toward NCAA screening program 
• Attitudes toward mandatory nature of testing 
• Awareness of testing and its purpose 
• Awareness of potential impact of SCT status 
• Confidence that trainer* intentions are in the best interest of the student-
athlete (*trainer defined as any coach or support training staff (e.g. 
strength coach)) 
• Importance accorded with sports participation 
• Informed consent to testing 
• Perceived risked associated with screening program 
• Reasons for involvement in sports 
• Understanding of SCT status 
2.2.2 Identifying and categorizing themes    
After transcripts were coded completely, the process of identifying and categorizing themes was 
conducted.  A theme describes an important aspect about the data in relation to the broader 
research question(s) and furthermore represents a pattern from the responses (Braun, 2006).  
Interviews were compiled into a master file, containing all transcripts with codes.  Every code, 
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previously described above, acted as a category for which themes were explored.  Participant 
responses for a given category were compared and summarized; themes were generated based on 
the integration of the descriptions provided by the participants.  A list of quotes, demonstrating 
the soundness of a given theme, was also noted during the analysis.     
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3.0  RESULTS 
3.1 SPECIFIC AIM 1 
Sixteen interviews were conducted with student-athletes from the University of Pittsburgh.  
Slightly more males participated in the study than females; a total of nine males and seven 
females were participants (see Figure 3).  Furthermore, three student-athletes revealed they were 
positive for SCT during the interviews.   
 
Figure 3 Participant Demographics 
 
Participant’s ethnicities were also obtained, eight individuals identified themselves as 
Caucasian, seven individuals identified themselves as African American, two individuals 
identified themselves as Asian, and one individual identified as Hispanic (see Figure 4).   
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Figure 4 Participant Ethnicities 
 
Interview days and locations were coordinated with each student-athlete as well as their 
respective athletic trainer, in order to avoid potential conflicts with academic or athletic 
schedules.  Student-athletes interviewed were members of various sports teams including 
baseball, football, soccer, softball, swimming, tennis, track, volleyball, and wrestling (see Figure 
5).  Interview times ranged from 10 – 30 minutes.  During the course of interviews it was 
discovered that not every student-athlete received genetic counseling as part of their SCT 
screening participation, although most received SCT literature regarding why student-athletes are 
being tested.  Three student-athletes (19%) did not receive formal genetic counseling; moreover 
one of those student-athletes did not receive SCT literature.   
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 Figure 5 Participant Athletic Involvement  
3.2 SPECIFIC AIM 2 
Themes emerging from the interviews were organized based on the coded transcripts, including: 
attitudes toward the University of Pittsburgh screening program, attitudes toward the NCAA 
screening program, attitudes toward the mandatory nature of testing, awareness of testing and its 
purpose, awareness of potential impact of SCT status, and perceived risks associated with the 
screening program.  Responses to most of the questions were similar across interviews.  Further 
analysis was completed to discover themes raised by student-athletes who received genetic 
counseling compared to those who did not receive counseling and also to evaluate the themes 
presented by student-athletes participants with SCT.  Select quotes from interviews are provided 
to help explicate each theme.  It is important to note, reference to a majority of student-athlete 
responses, is intended to represent a general consensus from the thematic analysis and does not 
suggest any level of statistical significance. 
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Attitudes toward the University of Pittsburgh screening program  
The majority of student-athlete participants were appreciative of the transparency of the 
University of Pittsburgh SCT screening program, which provided genetic counseling as part of 
the process.  Student-athletes were supportive of the counseling which included education about 
sickle cell and explanation of the rationale for screening.   
Student-athletes commented on how the counseling provided a comfortable level of 
understanding, stating: “…the counseling really helped me understand what was going on, why 
we were doing this…”  They offered other comments like “…they handed us a sheet explaining 
everything on the sheet so we didn’t have to sit there and read for twenty minutes…it was pretty 
informative and [re]assuring that what’s going on.” 
Student-athletes also appreciated the advantages of the coordinated nature of the 
University of Pittsburgh program that removed responsibility from the student-athlete to arrange 
for testing and concomitantly ensured compliance.  Student-athletes commented on the 
convenience of the process, for example, stating “…someone was explaining to me why I was 
getting it done and…I didn’t have to worry about doing it on my own, it was provided for me, 
which was nice.  And the fact that I actually knew what was happening was nice too.”  Student-
athletes were emphasized the benefits of keeping the process organized and uniform, rather than 
relying on individuals to seek the testing independently:  
…if you just tell some athletes to go get their blood tested, some of them will forget or  
just won’t do it and with making the test part of your physical, that you have to get done 
in order to participate, I feel like it puts less responsibility on the athletes to remember to 
do it and everyone knows they did it cause they’re with them. 
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A few student-athletes expressed concern over not being formally informed of a result 
(i.e., a negative result).  They were also concerned over screening programs where education was 
not provided.  Student-athletes wanted to have awareness of what was being asked of them.  As 
one participant commented, “I would definitely want to know why my blood’s getting drawn and 
I would be concerned if somebody just told me to go get my blood drawn and no reason why.  I 
would ask why?  For what?”   
 
Attitudes toward NCAA screening program 
The majority of student-athlete participants were supportive of the NCAA program and 
of continuing screenings in the future for all student-athletes.  One student-athlete made 
comments of support because of the realization that SCT is not exclusive to a specific racial 
group:  
...I think we should…test everybody, yeah we know it’s more dominant in African 
Americans but there are, in every genetic disorder, there’s also the select minorities that 
can also be affected…it’s good to branch out [and test every student-athlete for SCT]… 
Many student-athletes believed the screening program was the most effective way to establish 
individuals’ SCT status and commented on the importance of screening in order to avoid 
overlooking an individual who potentially could be positive for SCT: 
…we all get tested, so then we know and our coaches know, our trainers know; so I think 
that’s a good way of protecting us.” And one student-athlete added, “…genetically 
testing everybody is just more direct; you have it or you don’t and you go from there 
rather than taking the steps to caution yourself… 
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Some student-athletes commented that the NCAA is responsible for ensuring the detection of 
SCT for this population.  One remarked on the role of the institution:   
If an athlete had that [SCT], putting themselves in danger, working hard and exercising, 
you know it’s kind of on the college if you know one of their athletes has a health problem 
that could have been avoided. 
Student-athletes also acknowledged the importance of determining SCT status, for example:  
I think that at this level an athlete should know if they have that issue or not, and I think 
it’s right of the NCAA, yes it’s a lot of students, it’s a big process to go through for 
probably just a couple people, but at the same time [for] those couple people, I think that 
that’s worth it. 
Student-athlete participants were not in favor of universal interventions due their perception that 
they could hinder athletic performance.  Most student-athletes supported the benefit of 
identifying those with SCT, so those student-athletes could have specialized routines.   
Student-athletes commented, for example, that “…if you take more breaks, it may affect 
someone’s performance or something, like for those who really don’t have it [SCT positive].  But 
if you do have it then it can be more directed toward that athlete.” Student-athletes saw a distinct 
value afforded by detection through a screening program, stating, “I think everyone should just 
get tested…We should be able to push through work outs if we have the physical capacity to do 
so.” Another participant, commented, “...knowing that you have sickle cell trait or not, I think, 





Attitudes toward mandatory nature of testing 
 The majority of student-athletes commented that SCT is a sufficient reason as a health 
concern to mandate testing and discussed the benefit of learning one’s SCT status.  One student-
athlete stated, “And with testing, I do think it’s a good thing to test for certain things that could 
affect how you are as a player and as a person, since certain conditions can [impact your 
health].” Student-athletes commented on their perception of the significance of SCT, for 
example, saying, “…a big reason why everyone should be tested, because it’s better to know 
what everyone has, especially something as serious as sickle cell trait that could affect a student-
athlete that strongly.” And another student-athlete stated, “…knowing the line between this isn’t 
good for me and oh, I’m just working hard; I think that’s important, especially if you did test 
positive, being aware of that would probably be important.” 
Many student-athletes seemed to recognize that they had the right to sign a waiver to 
decline testing, although none chose that option.  Some comments acknowledged directly the 
option to decline, for example: “…it was optional; it is good to check…I had all the tests, so 
might as well [complete all tests offered by the institution prior to participation]…” 
 
Awareness of testing and its purpose 
 A majority of student-athletes were aware SCT testing was a part of the medical/physical 
examination prior to sports participation, but did not express substantial understanding of SCT.  
One student-athlete commented: 
…we showed up for our physicals and they just told us what tests we would be doing. 
Another said: 
 When we had to get our physical done, they told us all the tests that would be done. 
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Still another said:  
…we had a physical coming up and they were going to do sickle cell. 
Participants’ comments reflected a lack of concern regarding the SCT testing; for example, one 
student-athlete stated, “I didn’t really think about it too much.” 
 Some student-athletes expressed concern regarding the blood draw itself, but did not 
express concern about the testing objective (i.e. determining SCT status), for example, saying: 
…I had practice and I knew I was having blood taken, but they didn’t take much blood at 
all, so I wasn’t worried much once I saw it.  I was just worried I would be drained.  
Another admitted:  
I’ve always been squeamish around needles; that was my biggest concern… 
 
Awareness of potential impact of SCT status 
  Student-athletes generally thought testing positive for SCT was not likely, in part because 
their health or other family members had not been affected thus far; however, some expressed 
the realization that they might test positive.  Student-athlete made comments like,  
…I’m pretty sure I would know if I had sickle cell by now, so I’m not too worried about 
it. 
Or this: 
…I’m sure if I had had sickle cell then I probably would have noticed some fatigue or 
something like that. 
Some student-athletes stated their sense of reassurance based on apparent statuses of family 
members, for example, stating, “…I wasn’t concerned; my brothers didn’t have it.  I haven’t 
heard of it running in my family; since it’s genetic I would have known.” However, some 
 38 
student-athletes recognized the possibility and anxiety associated with testing positive, saying, 
for example: “…there’s always that paranoia, oh my gosh, what if I actually have it?” 
 Although student-athletes appeared to have a lack of understanding of SCT, they were 
aware of, and commented on, the influence a positive SCT result would have in their lives.  SCT 
would be an additional health condition to contend with or be cautious about.  They expressed 
concern that SCT would alter athleticism and potentially athletic ability.  SCT could make 
training more difficult especially when an individual already may another health issue to cope 
with (e.g. asthma).  Furthermore, student-athletes’ commented that the onus is on the individual 
to advocate for him/herself, if SCT positive.  One student-athlete commented on the challenges 
of keeping people aware of one’s positive SCT status:  
…trying to remind my coaches, my strength coaches, my athletic trainer, sometime they 
don’t remember because they’re taking care of so many people and so it really would 
have to be on me to make sure that I was properly being taken care of.  
Another student-athlete stated, “I would talk to coaches and staff and make sure that they were 
aware that I had this condition and that it needed to be closely monitored.” 
 Student-athletes understood the basic reproductive implications of SCT (e.g., the 
possibility of passing SCT to children: …it would have affected my kids possibly, cause I could 
pass on the trait to them.”  Another stated: “I’d want to see if my partner had it [SCT] because 
you gotta look out for your children.”  Although student-athletes’ lacked concern for other 
family members in relation to their test result, some did acknowledge the familial implications 
that exist, for example, commenting, “If I did test positive, I would probably tell my family that 
they might need to be tested because it runs in the family.  I would definitely inform family 
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members.”  Another acknowledged, “It could affect my family, it’s passed down genetically so 
maybe someone else has it and they don’t know…” 
 
Perceived risks associated with the screening program 
Student-athlete participants did not raise concerns regarding discrimination based on SCT 
status or recognize any potential for future or long-term discrimination.  One student-athlete 
stated, “...I wasn’t worried that I would be kicked off the team or anything like that.”  Most had 
no concerns regarding negative consequences related to SCT screening, making statements like 
“…why not check everyone?”  However, one student-athlete did comment on how a positive 
SCT result may lead to adverse implications for a student-athlete, commenting, “…if someone 
did test positive, [they] might not want that on the record because athletes may be treated 
differently, or their scholarship might be reduced…” 
 
Responses of those who did not receive genetic counseling 
Three participants reported that they did not receive genetic counseling.  They expressed 
uncertainty concerning the testing process, and a lack of understanding regarding the rationale 
for screening.  Moreover, they unaware of the waiver option and viewed the screening program 
as compulsory.  They made comments regarding the process such as, “I was wondering how they 
would do it or what would be involved in the testing.” And, “…if it’s required by all student-
athletes, then I guess it’s a big deal.” They also stated their apparent lack of choice to participate 
in testing, saying, “It was just something that I had to do, didn’t think much of it,” and, “...I’m 
not a big fan of blood work but I guess I had no choice.” 
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Participants who reported not receiving counseling also had a lack of understanding of 
the significance of SCT and conveyed a desire for more education, as well as the institution of a 
structure to ensure student-athletes are informed.  They commented, “…I want to know why it 
[SCT testing] is so important.” They also wanted to know, “…just what it [SCT] is or how it 
could affect you, if you had it, cause I didn’t know much about sickle cell.” 
 
Responses of those who are SCT positive 
 Participants who were SCT positive knew their SCT status prior to the NCAA screening.  
They viewed the testing as confirmatory, stating, “...I knew I had the sickle cell trait, so I wanted 
to see if I actually did have it.”  These participants with SCT were aware that they must be 
cautious of their health and stated, for example: “…if you have any, feel any type of 
lightheadedness or something like that, you should not just try to fight it out and keep practicing.  
Just stop and get some help.”  Those who were SCT positive also had an understanding of the 
reproductive consequences of SCT, commenting, “…if you get married and your wife has sickle 
cell trait too, you could have a kid that will probably have disease.  If your wife doesn’t have 
sickle cell trait or disease, your kid will probably have the trait.” 
 Finally, student-athletes with SCT did express initial concern that trainers would treat an 
individual differently based on their SCT status, for example, commenting, “I kind of thought 
that the trainers [would]…try to keep me from doing certain stuff.”  Another observed: “I 
thought they would baby me, like on the field or something, with the sickle cell trait…but it 
hasn’t been like that.”  
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3.3 SPECIFIC AIM 3 
Although student-athlete responses were supportive of the NCAA program, ethical analysis 
suggests that the NCAA SCT screening program has particular ethical shortcomings which the 
NCAA should address.  Because it is possible that a non-mandatory “opt-in” program, combined 
additionally with the implementation of universal precautions, could achieve the health-
promoting goals of the NCAA with regard to SCT, without incurring the ethical liabilities that 
are presented by the mandatory program, for the good of the student-athlete population and 
overall benefit for the collegiate environment.  A more thorough assessment can be found in the 
Discussion.   
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4.0  DISCUSSION 
4.1 INTERVIEWS AND THEMES 
Both aims of the research study were achieved and, as a whole, provide additional insight into 
the controversial nature of mandatory SCT screening.  The objective of conducting at least 
fifteen interviews was exceeded, with sixteen student-athlete interviews completed.  Student-
athletes offered sufficiently similar responses as to represent a general consensus, among those 
interviewed, regarding most points.  The interview process revealed that not every student-
athlete at the University of Pittsburgh received genetic counseling or educational literature prior 
to undergoing the SCT testing.  Analysis revealed that those without genetic counseling had less 
understanding regarding SCT, the screening process, and the rationale for screening. 
Student-athlete’ perceptions were effectively assessed through thematic analysis based on 
their interview responses.  Certain themes, such as student-athlete support of the NCAA SCT 
screening program and their lack of understanding of SCT are supported by past research and 
were shared by the participants.  Other themes, such as student-athletes not being in favor of 
universal implementations, have not been reported elsewhere in the literature and might be 
explored further in future research. 
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4.2 IMPLICATIONS FOR SCT SCREENING AND THE NCAA PROGRAM 
4.2.1 Assessment of Mandatory SCT Screening from the Perspective of a Public Health 
Intervention 
Before analyzing the justifiability of the mandatory nature of the NCAA SCT screening program, 
it is important to clarify what and who is being mandated.  Collegiate institutions are mandated 
to confirm SCT status of their student-athletes; and student-athletes’ mandatory medical 
examinations prior to participation include sickle cell solubility testing.  Student-athletes can 
“opt out” and decline testing if they sign a waiver and assume the health-related risks associated 
with being at risk of having SCT.  Nevertheless, student-athletes are embedded in a doubly or 
triply hierarchical structure.  They are students within an educational institution and thus subject 
to the authority of professors and administrators; they are athletes and subject to the authority of 
their coaches and trainers; and they may be beholden to the athletic department and their ability 
to continue to be eligible in order to receive a college education.  The structural position of 
student-athletes within these hierarchies suggests that there is good reason to question whether 
they feel empowered to refuse that which is offered to them as being for their own good, the 
good of their teammates, or the good of the school and its athletic program.  Therefore, their 
ability to give a truly informed consent or refusal may be undermined.  This is true even in the 
context that includes genetic counseling and an informed consent process for testing as is 
provided at the University of Pittsburgh.   
Mandatory screening programs can be effective as public health interventions; however, 
any mandatory intervention limits certain rights and liberties of an individual.  While a public 
health intervention like mandatory quarantine during an epidemic limits individuals’ freedom of 
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movement, and mandating participation in screening limits individuals’ rights to determine 
control of their bodies (e.g., whether or not to have blood drawn) and their right to refuse consent 
to such intervention.  Mandating an intervention limits an individual’s freedom or right to make 
an autonomous choice.  Autonomy refers to the capacity of competent individuals to be self-
determining, i.e., to determine what they do and what they allow to happen to them.  The right to 
exercise autonomy refers to this the right of self-governance.  The doctrine of informed consent– 
a key feature of ethical healthcare and research– seeks to respect this right of individuals to be 
self-determining.  However, truly mandatory interventions, like a fully mandatory screening 
program, do not permit an informed consent process.  Despite this infringement of autonomy, 
these programs may be justified by different ethical principles that are deemed to outweigh 
respect for autonomy in certain limited contexts.  
In some public health interventions, for example, concern to avoid serious risk to others’ 
health may outweigh an individual’s right to autonomy or freedom of action.  The harm principle 
maintains that individuals have freedom of action unless they place others at risk of harm 
(Gostin, 2000).  By virtue of the harm principle, substantial risk to others may be invoked to 
override and to justify an individual’s autonomous choice that presents that risk.  Although the 
harm principle may be used to justify situations such as mandatory quarantine to prevent the 
spread of an infectious disease or mandatory vaccination to promote herd immunity, it cannot be 
invoked to justify the mandatory nature of the NCAA SCT screening program.  SCT testing is 
performed for the potential health benefit of the person tested, not for the sake of other 
individuals or public’s health.  Because it is not the risk to other individuals, but a risk to the 
individual who is to be tested that is at the issue with the NCAA program, the harm principle 
cannot be used to justify the NCAA’s making its screening program mandatory.  Indeed, because 
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individual student-athletes are allowed to refuse testing, sign a waiver, and thereby assume the 
potential health risk associated with SCT, the NCAA’s program is not truly or fully mandatory at 
the level of the individual student-athlete.  Nevertheless, because of the strength of the 
presumption that all athletes should be, and will be, tested, it effectively functions as a quasi-
mandatory program.     
The justification for the NCAA’s SCT screening program resides in the goal of protecting 
each individual athlete from the risk to self that is posed by SCT.  A paternalistic intervention is 
one that interferes with a person’s freedom of action or autonomous choice with the intent of 
benefitting that person (Gostin, 2000).  The NCAA therefore acts paternalistically in overriding 
the student-athletes’ autonomous choice to be tested or not for their own sake.  The NCAA 
attempts to mitigate the risks of SCT by interfering with individual student-athletes’ self-
regarding behaviors and mandating that they be tested.  Although individuals do have the option 
to opt out of the NCAA program, this option may not present a true choice of which student-
athletes may voluntarily avail themselves.  The choice is presented by their coach, trainer, or 
other authority figure within their university and/or athletic department.  Student-athletes are not 
only in the habit of following the direction of their coaches, trainers, and teachers, but also may 
be completely dependent for their current education and future athletic career on pleasing their 
coaches and trainers, complying with their direction, being given sufficient playing time to 
demonstrate their skill, and so on.  These are not the conditions under which a student-athlete 
may be comfortable issuing an informed refusal of a recommended intervention that is supposed 
to be in his/her own interest. 
This situation is a primary reason that the mandatory nature of the NCAA SCT screening 
program is called into ethical question, particularly given the risks–and historical record–of 
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stigma and discrimination associated with SCT.  Therefore, it is appropriate to consider whether 
it is necessary and justifiable to mandate SCT screening.  Criteria developed by Gostin to 
evaluate the justifiability of mandatory interventions seeking the public’s health, may be used to 
evaluate the justifiability of this mandatory intervention that has the paternalistic goal of 
protecting student-athletes with SCT.                     
To justify being mandatory, a public health intervention should demonstrate that it 
addresses a significant risk, is an effective intervention, presents a reasonable cost, and justly 
distributes benefits, burdens, and costs (Gostin, 2000).  Moreover, any public health intervention 
that overrides individuals’ autonomous choice or infringes their liberty must do so as minimally 
as possible; that is, it must be the “least restrictive” alternative available (Gostin, 2000).  
Similarly, a paternalistic intervention must meet similar conditions in order to be justified.  These 
criteria then can be applied to mandatory SCT screening for student-athletes.   
To be justified, an intervention should be demonstrated to be an effective intervention 
with a reasonable cost (Gostin, 2000).  The NCAA screening program is estimated to prevent 
seven student-athlete deaths over a decade, and screening can be accomplished through a sickle 
cell solubility test which is considered relatively inexpensive (Harris, 2012; Tarini, 2012).  The 
targeted population for this screening program is, of course, the student-athletes; however, in 
order to comply with the NCAA mandate, the cost of screening is placed on the institutions at the 
Division I, II and III levels.  This financial cost can be substantial.  At the University of 
Pittsburgh each student-athletes receives Rapid Hemoglobin S, a test used to effectively quantify 
Hb S but is less expensive than hemoglobin electrophoresis (Edwards, 2009).  Since screening is 
coordinated, most student-athletes have their testing billed through the athletic department.  
Whether the costs are justified requires a normative judgment.  Whether they are distributed 
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fairly is a second question.  Both must be considered to justify mandating SCT screening and 
implementing the program as the NCAA does.  Consideration of these value-laden cost-focused 
questions is, however, beyond the scope of this project.  The question of the significance of the 
risk to be mitigated by SCT screening can be addressed to some degree, and indeed was an issue 
raised by student-athletes in interviews as part of this project.       
The SCT has been shown to be associated with a significant risk of sudden death in 
exercise-related conditions (Tsaras, 2009; Harris, 2012).  The NCAA views screening as 
necessary and as a way to provide targeted precautions for individual student-athletes (NCAA 
Sports Medicine Handbook, 2013-2014).  Student-athletes interviewed stated their belief that 
SCT was a significant risk that should be assessed in the athletic community.  Student-athletes 
also agreed with the NCAA and supported the mandatory SCT screening program based on the 
importance of identifying those with SCT.  Some of the student-athletes went further, suggesting 
it was the NCAA’s responsibility to ensure detection of SCT.  In contrast, the ASH and other 
organizations do not believe that the requisite connection between SCT and a significant health 
risk has been adequately established to warrant mandatory screening; they instead believe that 
more research is needed to understand the etiology of the increased risk of sudden death for 
individuals with SCT (Lawrence, 2010; O’Connor, 2012).  Although substantiating the risk is an 
essential component of establishing interventions, the effectiveness of the intervention should 
also concomitantly be evaluated.    
Student-athletes agreed the risk of student-athlete deaths and of SCT as a sufficient 
potential health concern to warrant an intervention.  Sickle cell solubility testing, however, can 
be unreliable and misleading.  The testing relies on the relative insolubility of deoxygenated 
hemoglobin S, which would occur if an individual had SCT or any other form of SCD 
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(O’Connor, 2012).  Moreover, solubility testing can provide false results and cannot accurately 
identify other common hemoglobin traits (e.g. Hb C), issues that contribute to its questionable 
status as a requirement (Aloe, 2011).  Student-athletes could have a false sense of security 
following a negative solubility test, as they may still be at risk for adverse health complications.  
The NCAA does require confirmatory testing of those with positive screening results 
through diagnostic testing such as hemoglobin electrophoresis or high performance liquid 
chromatography (HPLC) (Tarini, 2012; NCAA Sports Medicine Handbook, 2013-2014).  
However, when diagnostic testing is performed, there is the possibility to identify incidental 
findings beyond an individual’s SCT status (e.g. Hb C status).  The NCAA has not developed a 
policy to address these incidental findings, whereas the University of Pittsburgh not only reports 
the atypical hemoglobin present but also provides counseling regarding the implications.  Since 
student-athletes, in general, lack knowledge of SCT, it is reasonable to assume that they do not 
comprehend this aspect of screening (i.e., the possibility of discovering incidental findings) 
either.      
Student-athletes did not have comments concerning the scientific method of testing; 
rather their concerns focused on the discomfort or perceived loss of physical stamina associated 
with the blood draw, which is unavoidable if SCT status is being determined.  Student-athletes 
also commented on the advantage of the organized screening program’s removing responsibility 
from the student-athlete to arrange for testing.  Since student-athletes are required to have 
screening for SCT as part of the medical process (or sign a waiver and assume the risk of having 
undetected SCT), and nearly every student-athlete complies with this mandate, the program 
extends to a large collegiate community.  The ASH suggests this population could be protected 
through the implementation of universal interventions rather than genetically screening all 
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student-athletes for SCT (Lawrence, 2010).  It may be argued that implementing universal 
interventions–despite being applied to all student-athletes in a way that limits their training 
activity–would actually be the least restrictive means of addressing the risk of SCT, because it 
would be implemented as a part of normal training protocols.  It would not single out any 
individual to limit his/her actions or choices.  This universal intervention approach would also 
eliminate the risk of stigmatization those with SCT may experience, including the risk of 
internalized stigma, especially if effective education is not provided (Thompson, 2013).  Student-
athlete participants were not in favor of such measures, however; they connected the 
implementation of universal interventions with possible hindrance of athletic performance.  They 
did not appreciate that “leveling the playing field” for all student-athletes to the level that could 
be tolerated by those with SCT could benefit all student-athletes while avoiding the risk the 
identifying those with SCT may lead to individuals being treated differently both within and 
outside of their sport.  Moreover, the NCAA has not yet established any form of protection of 
individuals who test positive for SCT.  Although the NCAA has stated SCT is not a barrier for 
athletic participation, they have not made a formal regulation in the NCAA Sports Medicine 
Handbook to ensure individuals with SCT are not in jeopardy of adverse effects (e.g. loss of 
playing time) resulting from their SCT status.  Rather, the NCAA has merely suggested that 
institutions provide an environment where precautions can be activated.      
The mandatory nature of SCT screening is a major concern raised by opponents of the 
NCAA program.  Organizations, like the ASH, assert that the NCAA program is not justified and 
could further undermine an individual’s autonomy through breaching the confidentiality of the 
SCT test result and thus the individual’s privacy regarding his/her health status.  For example, an 
individual’s welfare would be undermined if institutions participating in the NCAA program 
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tolerated an environment that allows for discriminatory practices (SACHDNC, 2010; Grant, 
2013).  Confidentiality is related to how an individual’s information may be distributed, which 
can, in turn, protect an individual’s privacy (Francis, 2008).  Student-athletes waive, to some 
degree, their confidentiality when allowing educational institutions access to at least the part of 
their medical records that includes their SCT status.  But such student-athletes have a reasonable 
expectation that the confidentiality of that information will, in turn, be protected by the athletic 
departments that access it.   
Student-athletes interviewed appeared cognizant of this collegiate atmosphere, where at 
the University of Pittsburgh student-athletes release their complete medical records to the athletic 
department.  They did not, however, express any awareness of measures that would be taken to 
protect the confidentiality of that information in possession of the athletic department, aside of 
being a part of their file record.  Keeping such information confidential (i.e. protecting the 
informational privacy of the student-athletes) is important for both instrumental and intrinsic 
reasons.  Respecting individuals; privacy is an intrinsic part of respecting them as persons.  
Moreover, protecting the privacy of individuals’ health information has instrumental value in 
safeguarding them from stigma and discrimination.  Student-athletes are already mandated to 
partake in the screening program, which is an infringement on their autonomy; to subsequently 
present an environment in which their right to privacy can be violated would exacerbate this 
intrusion of their autonomy and risk their welfare.  Individuals with SCT risk their privacy being 
breached by the measures used by the NCAA to protect them–namely, the recommended 
precautions–since these allow individuals with SCT to be easily distinguished from because 
other teammates who would not be allowed the same accommodations (Thompson, 2013).  
Student-athletes interviewed with SCT responded differently regarding the importance of 
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keeping their status private.  One individual felt it was better to have teammates aware of the trait 
and possible complications.  Another individual did not want to reveal the trait status to 
teammates, although the student-athlete stated it was not due to concerns of discrimination but 
did not elaborate further.                   
Student-athletes with SCT can be accomplished athletes.  There is no reason that 
individuals with SCT should be marginalized, a view both the NCAA and the ASH accept 
(Nelson, 2013; NCAA Sports Medicine Handbook, 2013-2014).  Nevertheless, concern about the 
marginalization and stigmatization of those with SCT, and the potential for discrimination 
against them, have been raised.  Past SCT screening programs, specifically in the military and 
governmental population-wide screening programs, have a history of discrimination or 
stigmatization (SACHDNC, 2010; Grant, 2013).  The NCAA mandatory SCT screening program 
will raise much awareness of SCT with the potential for misinformation that may lead to undue 
alarm and create an atmosphere of stigmatization and discrimination for those with SCT 
(Bonham, 2010; SACHDNC, 2010).  Moreover, as discussed above, there is a history of 
discrimination against those with sickle cell disease and SCT, particularly by those who failed to 
distinguish the two conditions.  Student-athlete participants did not volunteer information 
indicating awareness of this history or reveal concerns about stigmatization or discrimination.  
Further, they did not anticipate being dissuaded from continuing athletics if they were found to 
have SCT.   
Since most student-athletes are unaware of the history of prejudice pertaining to SCT this 
may explain their collective lack of concerns (Lawrence, 2014).  However, the NCAA program 
will inevitably reveal a health issue disproportionately affecting African Americans, due to the 
greater incidence in that population.  Therefore, there is the potential for complications of racial 
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discrimination to develop.  It is important to note, that University of Pittsburgh student-athletes 
with SCT did express initial concern over being treated differently based on their SCT status; the 
student-athletes stated this was not found to be well-founded, and they were not concerned about 
stigmatization or discrimination in the athletic setting.  This amelioration of initial concern may 
be attributed to the strong educational approach taken at the University of Pittsburgh, which 
provides detailed SCT counseling for an individual positive for SCT and also for their trainers.  
The method attempts to ensure all parties are well-informed regarding the significance of SCT.  
Of course, such education can only reach those involved in the athletic department; other entities 
that might stigmatize or discriminate on the basis of SCT or race, would not receive such 
education.  To some degree, education and genetic counseling provides resources for individuals 
to protect themselves against stigmatization and discrimination (O’Connor, 2012), which would 
allow for potential burdens associated with the screening program to be partly offset.  Educating 
the potential victims of stigma and discrimination, however, does not address the misinformation 
itself or ill-intent of those who perpetrate stigmatizing or discriminatory practices.     
The NCAA SCT screening program is unethical as currently conducted due to the 
implied mandatory nature of testing at the individual level.  Recognizing the possibility of harms 
such as discrimination, controversy surrounding scientific significance associated with SCT, the 
limitations surrounding the effectiveness of the interventions, and the reality that the program is 
not the least restrictive option which the NCAA could implement; it is difficult to justify even 
implicitly mandating that student-athletes be tested.  The NCAA needs to address these concerns.  
Similar to previously implemented mandatory screening programs, like NBS, the relevance in 
determining whether it is necessary or appropriate to mandate screening should be considered.  
Past research regarding NBS have revealed a debate between whether programs should be 
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elective and voluntary or whether screening can be appropriately mandatory.  Since most, if not 
all, student-athletes, it is assumed, would freely comply with SCT testing if genetic counseling 
was provided, the implied NCAA mandate of testing is not necessary.  Steps need to be taken to 
ensure that student-athletes realize that they have the choice of refusing the offer of testing.  
With adequate genetic counseling, it is unlikely that many would refuse testing that affords them 
benefit.  Especially if universal precautions are implemented so that fellow teammates cannot 
identify those who test positive, because everyone is subject to the same level of rigor and safety 
during training, student-athletes would rarely have reason to reject the offer of learning their 
SCT status. 
Although genetic counseling cannot eliminate the possibility of discrimination, it can 
provide a compromise between the NCAA and the ASH and enable student-athletes to be treated 
in the most ethical, least infringing manner.  Mandating genetic counseling and allowing for SCT 
screening to be voluntary is the best method for screening available.  The benefit of counseling is 








4.2.2 Assessment of Genetic Counseling in the SCT Screening Process 
Genetic counseling is a principle-based ethical process which strives to ensure beneficence, 
nonmaleficence, and autonomy (Uhlmann, 2009).  Informed consent is particularly relevant 
during the genetic counseling process.  Informed consent in the genetic screening context, 
implies that prior to genetic testing, individuals are allowed (Hodge, 2004):        
• explanations of the nature and scope of information being gathered 
• meaning of possible results 
• meaning of the underlying condition 
• any risks that may be associated through testing  
The NCAA cannot be considered to implement these measures due to the mandatory nature of its 
SCT screening program and the integral incompatibility between ensuring the opportunity to 
give informed consent–which includes a right to informed refusal–and mandating participation.  
However, the University of Pittsburgh SCT screening program attempts to provide an informed 
consent process which respects student-athletes’ autonomy within the genetic counseling 
provided as part of the University’s SCT screening program (Uhlmann, 2009).  Genetic 
counseling prior to undergoing SCT testing includes review of the screening rationale, the types 
of possible results, the implications of results, symptoms and precautions for SCT, information 
about testing procedure, and the reproductive significance of SCT.  Furthermore, each student-
athlete is asked to sign a consent form that documents what is explained about the accuracy and 
confidentiality of testing, the implications of results, and the potential for incidental findings.  
Individuals with positive SCT results are given post-test counseling which reviews similar 
information as the pre-test counseling in a private setting with a licensed genetic counselor.    
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Maintaining a true process of informed consent within screening programs is beneficial 
but can challenging depending on by how much emphasis is placed on student-athletes’ 
comprehension and knowledge of a subject, such as SCT (Dunn, 2007).  Research, including this 
study, has highlighted the lack of understanding of SCT among student-athletes (Lawrence, 
2014; Costanzo, 2011; Thompson, 2011).  Interestingly, most student-athletes interviewed 
considered themselves informed prior to undergoing SCT screening, and they attributed this to 
the genetic counseling.  However, they did not volunteer substantial evidence of understanding 
SCT or the implications of testing positive.  Student-athletes were concerned about screening 
programs at other institutions not providing a similar genetic counseling process.   
The University of Pittsburgh SCT screening program is believed to be the only institution 
that includes genetic counseling.  Genetic counseling goes beyond merely educating an 
individual.  Education involves attempting to teach information, whereas genetic counseling 
seeks to enable an individual can make an autonomous decision while considering the meaning 
of the information (Kessler, 1997).  As discussed above, it is difficult to imagine that student-
athletes make an autonomous decision within the contexts of their athletic departments and the 
mandatory nature of the NCAA screening program.  On the other hand, at the University of 
Pittsburgh, both the education and the pre-test genetic counseling afforded student-athletes 
include the fact that they may opt out of testing.     
Although the NCAA has recently required mandatory SCT education [See Appendix 
B.4], which should include information on the risks, impact, and precautions associated with 
SCT, they have not issued guidelines to ensure student-athletes are receiving a consistent level of 
education or recommended how institutions should carry out this education.  The University of 
Pittsburgh program exceeds the base level of education and counsels student-athletes on the 
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types of results and their implications, including implications for reproduction.  Counseling 
allows for understanding; in regard to SCT screening, it provides student-athletes awareness of 
the testing and its risks and benefits.  The possibility of anxiety associated with genetic testing 
has been shown to be allayed by genetic counseling (Atkin, 1998).  Significantly, however, it is 
the University of Pittsburgh, not the NCAA that mandates genetic counseling.   
Student-athlete participants were supportive of the University’s genetic counseling 
program.  However, this study revealed that even at the University of Pittsburgh, some student-
athletes did not receive genetic counseling prior to screening.  These student-athletes had 
uncertainty regarding screening and expressed a desire for more education.  Some student-
athletes’ comments reflected other areas for improvement as well.  The psychological and social 
implications involved in genetic screening where individuals may be identified as carriers is 
often complicated by the process of providing results (Atkin, 1998).  Student-athletes with SCT 
did not express concern about how results were revealed to them, although these student-athletes 
were aware of their status prior to screening.  Some student-athletes were concerned about not 
being told a negative result.  While, the athletic department receives documentation of each 
student-athletes’ SCT status, a negative result is not formally given to student-athletes.  This 
relatively simple issue can be corrected by providing student-athletes who screen negative for 
SCT with a letter stating their status and explaining both the significance of that result and its 
limitations, given the mode of testing employed.  Other student-athletes suggested improving the 
ease by which student-athletes have avenues to disclose prior testing results.  However, for 
student-athletes to avoid confirmatory SCT testing, the NCAA requires that they provide official 
documentation of a prior test result, such as NBS results which are difficult to obtain (Lawrence, 
2010; NCAA Sports Medicine Handbook 2013-2014).   
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The ASH continues to argue the NCAA screening policy is not the least burdensome 
policy option available and calls for universal interventions (Thompson, 2013).  Nonetheless, 
past research and this research has shown student-athlete acceptance of mandatory screening and 
preference to either incorporate or continue genetic counseling as part of screenings into the 
future (Thompson, 2011).  Genetic counseling allows for the least restriction of individual 
liberties, by protecting and promoting an individual’s autonomy as much as possible within a 
setting in which screening is quasi-mandatory.  Therefore, the NCAA should consider mandating 
that genetic counseling be included in SCT screening programs, to afford all student-athletes the 
benefit experienced by student-athletes at the University of Pittsburgh.    
4.3 STUDY LIMITATIONS 
Although the findings of this study have afforded a greater understanding of student-athlete 
perceptions on the NCAA screening program, as well as provide data to ground some 
recommendations for the program to improve its attention to potential ethical concerns and 
ensure genetic counseling for all those tested, the study has some limitations.  First, participants 
were recruited with an emailed invitation; however, student-athlete trainers were essential in 
scheduling interviews with the student-athletes.  This situation may not have provided student-
athletes with the most minimal possibility of inappropriate or undue influence to participate.  
This potential for inappropriate influence during the recruitment process was alleviated in part by 
each student-athlete partaking in a verbal informed consent, stating their participation was 
voluntary, prior to beginning the interview.   
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The sample size of sixteen participants was relatively small as well.  While responses 
were similar within the study population, these findings cannot be interpreted to express 
collective beliefs held by all student-athletes.  Finally, throughout the interview process, 
participants were asked at times to elaborate on their responses.  However, ethical issues, 
specifically privacy, stigmatization, or discrimination, were not probed unless a participant 
brought forward those concerns.  In general, interviewing more student-athletes from the 
University of Pittsburgh and other universities– and interviewing them more in-depth with more 
probing of longer-term implications and possible ethical concerns– could provide additional 
understanding and also substantiate this project’s findings.   
4.4 FUTURE CONSIDERATIONS 
The NCAA has shown no indication of discontinuing the SCT screening program, and instead 
expanded the program as mandatory for Division I, II, and III student-athletes in the past four 
years.  Organizations such as the ASH and the SACHDNC continue to oppose the mandatory 
program, cautioning the potential harm allotted to the student-athlete community and specifically 
those with SCT.  These concerns are significant and should be addressed by the NCAA.  
However, student-athletes participants found SCT testing to be a positive program of the NCAA 
and information they valued as athletes.  Their lack of understanding of some of the long-term 
implications of testing positive should be improved by the NCAA making measure to ensure 
adequate education is provided and possibly though mandating a universal genetic counseling 
process for the screening process.   
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The potential for other mandatory screening programs to be implemented is not an 
unlikely prospect.  Therefore, the ethical status of the SCT screening program is essential to 
provide a model for potential public health screening programs in the future.  Other forms of 
qualitative and quantitative analyses can be utilized to assess certain issues regarding the NCAA 
mandatory SCT screening program.  The current study was not able to address why some 
student-athletes at the University of Pittsburgh did not receive genetic counseling as part of their 
SCT screening process.  Future studies may evaluate if this is a common occurrence and what 
steps may be taken to avoid such instances from happening.  This study also revealed that those 
with SCT were initially concerned of how their status would affect their athletic involvement.  
Although, these concerns proved unfounded at the University of Pittsburgh, future studies may 
consider assessing the views of a larger number of student-athletes with SCT to determine 
whether this targeted population, revealed by screening, has to contend with an environment that 
infringes further on their liberties, through discrimination or stigma, as the ASH suggests may be 
occurring.  Finally, additional evaluation is needed to determine student-athlete perceptions and 
attitudes at other institutions.  Among the questions to explore are whether student-athletes lack 
knowledge of SCT and want genetic counseling as part of screening, as well as whether student-
athletes are aware of the potential risks of SCT screening identified by the ASH, and if they are 
aware, whether they lack concern about these risks.   
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5.0  CONCLUSION 
This study offers insights into the perceptions of student-athletes in regard to the mandated 
NCAA SCT screening program, as well as ethical insight into the controversy in the literature 
that has surrounded the NCAA program.  Participants interviewed were supportive of the NCAA 
policy and were not concerned about issues groups like the ASH suggest, for example, 
stigmatization and discrimination.  What is unclear from this study is whether those interviewed 
actually evaluated those risks and were not concerned about them, or whether they were simply 
unaware of the history and future potential for stigma and discrimination.  Student-athletes were 
in favor of genetic counseling.  They were hesitant to favor universal interventions because they 
believed, correctly or not, that their performance as an athlete would be hindered.  This study 
reflects the attitudes of a small number of student-athletes at the University of Pittsburgh.  
Therefore, future studies are needed in order to evaluate the perceptions of student-athletes at 
other institutions and gain a more comprehensive assessment of how this population views the 
NCAA SCT screening program, particularly by probing more carefully what the student-athletes 
understand about the broader implications of a mandatory screening program and about the 
social risks of testing positive for SCT. 
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APPENDIX A: RESEARCH PROJECT APPROVAL AND RELEVANT FORMS 
This research study was approved by the University of Pittsburgh Institutional Review Board.  
Additional materials relating to the study procedure can be found below. 
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A.1 INSTITUTIONAL REVIEW BOARD APPROVAL  
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A.2 PARTICIPATION RECRUITEMENT EMAIL  
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A.3 SCRIPT FOR VERBAL CONSENT OF INTERVIEWS  
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APPENDIX B: OFFICIAL INSTITUTIONAL SCT DOCUMENTS 
The University of Pittsburgh has developed policies and procedures to ensure, and consequently 
exceed, compliance with the mandatory NCAA SCT screening program.  The university has 
also, with the help of Children’s Hospital of Pittsburgh, created informative literature for each 
student-athlete to receive during the SCT screening process.  Various SCT materials relating to 
the University of Pittsburgh SCT screening program can be found below.    
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B.1 SICKLE CELL TRAIT SCREENING INFORMED CONSENT  
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B.2 SICKLE CELL TRAIT SCREENING WAIVER RELEASE  
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